These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 16788002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.
    Ahn A, Park CJ, Cho YU, Jang S, Seo EJ, Lee JH, Yoon DH, Suh C.
    Ann Lab Med; 2020 May; 40(3):193-200. PubMed ID: 31858758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mast cells (MC) excess in a bone marrow (BM) associated with lymphoplasmacytic cells (LPC) in a 55-Y-old patient with Waldenström's macroglobulinemia (WM).
    Gentelet M, Demulder A.
    Ann Biol Clin (Paris); 2021 Feb 01; 79(1):92-93. PubMed ID: 33527905
    [No Abstract] [Full Text] [Related]

  • 5. CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
    Ho AW, Hatjiharissi E, Ciccarelli BT, Branagan AR, Hunter ZR, Leleu X, Tournilhac O, Xu L, O'Connor K, Manning RJ, Santos DD, Chemaly M, Patterson CJ, Soumerai JD, Munshi NC, McEarchern JA, Law CL, Grewal IS, Treon SP.
    Blood; 2008 Dec 01; 112(12):4683-9. PubMed ID: 18216294
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting CD40 in Waldenström's macroglobulinemia.
    Lee M, Advani R.
    Clin Lymphoma Myeloma; 2009 Mar 01; 9(1):87-9. PubMed ID: 19362983
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
    Jalali S, Ansell SM.
    Best Pract Res Clin Haematol; 2016 Jun 01; 29(2):148-155. PubMed ID: 27825460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
    Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED.
    Mod Pathol; 2009 Jun 01; 22(6):807-16. PubMed ID: 19287458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sánchez-Guijo F, Sánchez ML, Escribano L, Bárez A, Moro MJ, Hernández J, Aguilera C, Cuello R, García-Frade J, López R, Portero J, Orfao A.
    Semin Oncol; 2003 Apr 01; 30(2):187-95. PubMed ID: 12720134
    [Abstract] [Full Text] [Related]

  • 13. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP, Hatjiharissi E, Leleu X, Moreau AS, Roccaro A, Hunter ZR, Soumerai JD, Ciccarelli B, Xu L, Sacco A, Ngo HT, Jia X, Yang C, Adamia S, Branagan AR, Ho AW, Santos DD, Tournilhac O, Manning RJ, Leduc R, O'Connor K, Nelson M, Patterson CJ, Ghobrial I.
    Clin Lymphoma Myeloma; 2007 Aug 01; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [Abstract] [Full Text] [Related]

  • 14. Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia.
    Sacco A, Aujay M, Morgan B, Azab AK, Maiso P, Liu Y, Zhang Y, Azab F, Ngo HT, Issa GC, Quang P, Roccaro AM, Ghobrial IM.
    Clin Cancer Res; 2011 Apr 01; 17(7):1753-64. PubMed ID: 21355079
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH, Taha GM, Mohamed SO, El-Hadidy KS.
    Hematology; 2007 Aug 01; 12(4):301-7. PubMed ID: 17654056
    [Abstract] [Full Text] [Related]

  • 16. The bone marrow microenvironment in Waldenström macroglobulinemia.
    Agarwal A, Ghobrial IM.
    Clin Lymphoma Myeloma Leuk; 2013 Apr 01; 13(2):218-21. PubMed ID: 23490994
    [Abstract] [Full Text] [Related]

  • 17. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
    Sacco A, Desantis V, Celay J, Giustini V, Rigali F, Savino FD, Cea M, Soncini D, Cagnetta A, Solimando AG, D'Aliberti D, Spinelli S, Ramazzotti D, Almici C, Todoerti K, Neri A, Anastasia A, Tucci A, Motta M, Chiarini M, Kawano Y, Martinez-Climent JA, Piazza R, Roccaro AM.
    Blood; 2023 May 25; 141(21):2615-2628. PubMed ID: 36735903
    [Abstract] [Full Text] [Related]

  • 18. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia.
    Shiokawa S, Suehiro Y, Uike N, Muta K, Nishimura J.
    Am J Hematol; 2001 Nov 25; 68(3):139-43. PubMed ID: 11754393
    [Abstract] [Full Text] [Related]

  • 19. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B, Wang Z, Singleton TP, Bennington A, Fritschle W, Bennington R, Brodersen LE, Wells DA, Loken MR, Zehentner BK.
    Leuk Res; 2016 Dec 25; 51():41-48. PubMed ID: 27890075
    [Abstract] [Full Text] [Related]

  • 20. CD154-CD40 interactions in the control of murine B cell hematopoiesis.
    Carlring J, Altaher HM, Clark S, Chen X, Latimer SL, Jenner T, Buckle AM, Heath AW.
    J Leukoc Biol; 2011 May 25; 89(5):697-706. PubMed ID: 21330346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.